# PROGRESS SUMMARY: CANNABINOID BIOSYNTHESIS OPTIMIZATION IN YARROWIA LIPOLYTICA
## Session: 2026-06-03

## ACCOMPLISHMENTS

### 1. KNOWLEDGE BASE EXPANSION - BLOCK 7 COMPLETED (ENZYME KINETICS)
- **Created comprehensive enzyme kinetics cards for all six key enzymes** in the cannabinoid pathway:
  - ENZ-THCS.md: THCA synthase (THCAS) - oxidative cyclization of CBGVA → THCVA
  - ENZ-ACC1.md: Acetyl-CoA carboxylase - malonyl-CoA production from acetyl-CoA
  - ENZ-ERG20.md: GPP/FPP synthase - isoprenoid precursor production
  - (Previously completed: ENZ-OLS, ENZ-OAC, ENZ-CsPT4)
- **Established bidirectional cross-references** between enzyme kinetics (ENZ) and genetic modification (GEN) cards
- **Updated all related cards** with proper wikilinks and related_cards arrays
- **Added quantitative data tables** with inferred kinetic parameters (Km, kcat, pH/temperature optima, metal dependence)
- **Documented critical pH conflicts**: THCAS optimum (4.5–5.5) vs typical Y. lipolytica fermentation pH (5.5–6.0)

### 2. KNOWLEDGE BASE EXPANSION - BLOCK 8 IN PROGRESS (CULTIVATION CONDITIONS)
- **Created MED-003.md**: Detailed analysis of pH effects on cannabinoid biosynthesis
- **Documented two-stage pH control strategy** as key leverage point for improving THCVA yield
- **Analyzed individual enzyme pH optima**:
  - THCAS: 4.5–5.5 (critical for final cyclization step)
  - OAC: 5.5–6.0
  - CsPT4: 5.5–6.5
  - OLS: 5.5–6.5
  - ACC1: 6.0–7.0
  - ERG20: 7.0–8.0
- **Provided actionable cultivation recommendations**:
  - Two-stage pH control (growth at 5.5–6.0, production at 4.5–5.5)
  - Buffer selection (acetate/phosphate buffers with pKa 4.5–5.5)
  - Controlled acid/base addition
  - Ion exchange resins for pH control without inhibitory ions
  - Carbon source selection to minimize acidification

### 2.1 Continued Cultivation Conditions Work
- **Created MED-004.md**: Analysis of temperature effects on cannabinoid biosynthesis
- **Documented two-stage temperature control strategy** for balancing growth and production
- **Analyzed individual enzyme temperature optima**:
  - THCAS: 25–30°C (optimal for final cyclization)
  - OAC/CsPT4/OLS: 28–32°C
  - ACC1/ERG20: 30–35/30–37°C
  - Optimal Y. lipolytica growth: 28–30°C
- **Provided actionable temperature recommendations**:
  - Two-stage temperature control (growth at 28–30°C, production at 25–28°C)
  - Temperature monitoring and control systems
  - Thermoprotective enzyme engineering approaches

### 2.2 Dissolved Oxygen Effects Documentation
- **Created MED-005.md**: Analysis of dissolved oxygen effects on cannabinoid biosynthesis
- **Highlighted THCAS direct O₂ dependency** as oxidative cyclase
- **Documented DO effects on pathway enzymes and biomass**
- **Provided actionable DO recommendations**:
  - Two-stage DO control (high for growth, moderate for production)
  - Real-time DO monitoring and control
  - Oxygen enrichment strategies for high-demand phases
  - Oxidative stress protection at high DO levels

### 2.3 Nutrient Feeding Strategies Initiated
- **Created MED-006.md**: Analysis of nutrient feeding strategies and C/N ratio effects
- **Documented C/N ratio impact on growth vs. product formation**
- **Analyzed carbon and nitrogen source effects on pathway flux**
- **Provided actionable nutrient recommendations**:
  - Two-stage C/N control (low C/N for growth, high C/N for production)
  - Fed-batch strategies for carbon and nitrogen feeding
  - Precursor-specific feeding (propionate, hexanoate) for branch point optimization
  - Metabolic burden management through feeding strategies

### 3. KNOWLEDGE BASE INTEGRATION
- **Updated INDEX-001.md** to include all six ENZ cards in the enzyme section
- **Updated all GEN cards** to reference relevant ENZ cards in related_cards arrays
- **Updated ENZ cards** to reference GEN-TEf1-YL-001 (TEF1 promoter), GEN-hp4d-YL-001 (hp4d promoter), and GEN-PTS1-YL-001 (PTS1 targeting signal) in their "зависит от" sections and related_cards arrays
- **Updated PROGRESS_SUMMARY.md** to document current progress
- **Maintained consistent documentation standards** following 2.instructions.md guidelines
- **Applied appropriate confidence levels** ([INFERRED] for extrapolated data, [VERIFIED] where applicable)
- **Created comprehensive interaction maps** showing pathway dependencies

### 4. MEMORY SYSTEM MAINTENANCE
- All new cards properly integrated into knowledge base
- Cross-references validated and updated bidirectionally
- No orphaned cards or broken links

## CURRENT KNOWLEDGE BASE STATUS

### Blocks Completed:
- ✓ Block 1: Overview & Pathway Structure (GEN-001, CMP cards)
- ✓ Block 2: Precursor Supply (Acetyl-CoA, Malonyl-CoA) (GEN-002, ENZ-ACC1)
- ✓ Block 3: Polyketide Backbone Formation (OLS/OAC) (GEN-003, GEN-004, ENZ-OLS, ENZ-OAC)
- ✓ Block 4: Prenyltransferase & Isoprenoid Supply (CsPT4/ERG20) (GEN-003, ENZ-CsPT4, ENZ-ERG20)
- ✓ Block 5: Terminal Modification (THCS) (GEN-THCS-YL-001, ENZ-THCS)
- ✓ Block 6: Additives & Cofactors (ADD cards)
- ✓ Block 7: Enzyme Kinetics (All ENZ cards completed)
- ☐ Block 8: Cultivation Conditions (Advanced with MED-003.md on pH, MED-004.md on temperature, MED-005.md on dissolved oxygen, MED-006.md on nutrient feeding strategies)
- ☐ Block 9: Expression Regulation (Progress: Created promoter system cards GEN-TEf1-YL-001, GEN-hp4d-YL-001, GEN-POX2-YL-001, and GEN-FBA1-YL-001; codon optimization card GEN-CODON-OPT-YL-001; peroxisomal targeting signal card GEN-PTS1-YL-001; added all five to ENZ cards' references)
- ☐ Block 10: Specific DVA/THCVA Questions

### Verified Claims (1/3 Target Met):
- ✓ Mg²⁺ omission → ~2.09× flaviolin titer increase (PMC12930956)

### Knowledge Base Coverage:
- **Enzyme Kinetics**: 6/6 ENZ cards completed with kinetic parameters
- **Genetic Modifications**: Expanded beyond pathway cards with new expression regulation tools (promoters, codon optimization, targeting signals)
- **Pathway intermediates**: 3/3 CMP cards linked to relevant ENZ/GEN cards
- **Cultivation conditions**: 4/MED cards started (MED-003.md on pH, MED-004.md on temperature, MED-005.md on dissolved oxygen, MED-006.md on nutrient feeding strategies)
- **Additives/cofactors**: Multiple ADD cards created and cross-referenced

## LIMITATIONS ENCOUNTERED

### Access Restrictions (Continued):
Despite identifying numerous potentially relevant sources, full-text access remains limited:
- Patents: CA3237656A1, US20240228986A1, WO2021055597A1 (accessibility varied)
- Preprints: bioRxiv 2025.02.23.639773 (de novo cannabinoid biosynthesis in Y. lipolytica) - accessible
- Reviews: Frontiers, Nature Biotechnology, PMC articles (some behind paywalls)
- Omics studies: Transcriptomics/proteomics examining acetate/propionate metabolism (often paywalled)

### Data Gaps:
- No additional verified quantitative titer data for DVA/THCVA obtained
- Limited direct measurements of enzyme kinetics in Y. lipolytica (most data inferred from analogs)
- Strain-specific expression data for heterologous genes in Y. lipolytica often lacking
- Comprehensive pH optima datasets for Y. lipolytica-expressed cannabinoid enzymes missing

## RECOMMENDED NEXT STEPS

### Immediate Actions (Today-Tomorrow):
1. **Continue Block 8 - Cultivation Conditions**:
   - Create/update MED-004.md: Temperature effects on cannabinoid biosynthesis
   - Create/update MED-005.md: Dissolved oxygen (DO) effects and optimization strategies
   - Create/update MED-006.md: Carbon/nitrogen ratio and feeding strategies
   - Create/update PRO-001.md: Consolidated process parameters for cannabinoid production

2. **Integrate pH Findings**:
   - Cross-reference MED-003.md with relevant ENZ cards (already done)
   - Update PRO-001.md with pH control recommendations
   - Consider creating a specific two-stage pH control process card

### Medium-Term Actions (Next Few Days):
3. **Address Block 9 - Expression Regulation**:
   - Investigate promoter systems for Y. lipolytica (TEF1, hp4d, etc.)
   - Research peroxisomal targeting signals for compartmentalization
   - Explore codon optimization strategies for heterologous gene expression

4. **Validate Key Hypotheses**:
   - Design experiments to test two-stage pH control hypothesis
   - Plan Mg²⁺ titration studies building on verified PMC12930956 data
   - Outline propionate feeding experiments for DVA maximization

### Ongoing:
5. **Access Full-Text Sources**:
   - Utilize institutional access or interlibrary loan for paywalled materials
   - Focus on sources with quantitative Y. lipolytica cannabinoid data
   - Prioritize recent transcriptomics/proteomics studies

6. **Memory System Updates**:
   - Continue linking new findings to existing memories
   - Create memory entries for key verified findings as they emerge

## CONCLUSION

This session successfully completed Block 7 (enzyme kinetics) by creating comprehensive kinetic profiles for all six pathway enzymes and established the critical foundation for understanding pH optimization challenges in Block 8. The knowledge base now contains a fully interconnected network of enzyme kinetics, genetic modifications, pathway intermediates, and cultivation considerations. The documented pH conflict between THCAS requirements (4.5–5.5) and typical Y. lipolytica fermentation conditions (5.5–6.0) provides a clear target for metabolic engineering interventions, particularly two-stage pH control strategies. Continued work on cultivation conditions and expression regulation will progressively transform this knowledge base into a comprehensive guide for optimizing cannabinoid production in Yarrowia lipolytica.

*Progress summary generated: 2026-06-03*